RxDoctor Payments Data

David Humphrey, MD

Internal Medicine · Asheville, NCNPI 1972592301

Payments from drug & device makers

$1,581in general payments, 2019–2025

Across 41 payments — averaging $38.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$444
  • Tactile Systems Technology Inc$209
  • Avita Medical Americas, LLC$190
  • Inari Medical, Inc.$145
  • Novo Nordisk$125
  • Solventum Corporation$88
  • plus $380 from 9 others

What the payments were for

  • Food & beverage$1,56399%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,581 in reported general payments places this provider in the 75th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$134,475
Medicare patients
372
Services billed
1,957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin Sulfate14$32,189
Gentamicin Sulfate152$5,363
Linezolid15$1,397
Doxycycline Hyclate52$622
Mupirocin67$540
Cephalexin29$438
SsdSilver Sulfadiazine12$376
Cefdinir24$341
Nystatin16$241
Triamcinolone Acetonide12$198
Cefadroxil11$195
Ciprofloxacin Hcl13$73
Levofloxacin14$72

Paid to pharmacies, not to this prescriber.

Other internal medicine in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →